
Sign up to save your podcasts
Or


Dr. Guymer discusses the results of the FLUID study which investigated whether some residual sub retinal fluid can be tolerated in neovascular macular degeneration.
Full reference:
Tolerating Subretinal Fluid in Neovascular Age-Related Macular Degeneration Treated with Ranibizumab Using a Treat-and-Extend Regimen. Guymer, Robyn H.Chang, Andrew et al. Ophthalmology, Volume 126, Issue 5, 723 - 734
By Keyvan Koushan, MD, FRCSC4.4
1111 ratings
Dr. Guymer discusses the results of the FLUID study which investigated whether some residual sub retinal fluid can be tolerated in neovascular macular degeneration.
Full reference:
Tolerating Subretinal Fluid in Neovascular Age-Related Macular Degeneration Treated with Ranibizumab Using a Treat-and-Extend Regimen. Guymer, Robyn H.Chang, Andrew et al. Ophthalmology, Volume 126, Issue 5, 723 - 734

43 Listeners

18 Listeners

97 Listeners

5 Listeners

4 Listeners

8 Listeners

22 Listeners

52 Listeners

10 Listeners

16 Listeners

18 Listeners

0 Listeners

1 Listeners

19 Listeners

0 Listeners